APA

Campillo A., Amorena E., Ostiz M., Kutz M. & LaIglesia M. (20180102). [10-day triple therapy with esomeprazole 40 mg/12 h vs. quadruple concomitant non-bismuth therapy as first line treatment for Helicobacter pylori infection]. : Gastroenterologia y hepatologia.

Chicago

Campillo Ana, Amorena Edurne, Ostiz Miriam, Kutz Marcos and LaIglesia Matilde. 20180102. [10-day triple therapy with esomeprazole 40 mg/12 h vs. quadruple concomitant non-bismuth therapy as first line treatment for Helicobacter pylori infection]. : Gastroenterologia y hepatologia.

Harvard

Campillo A., Amorena E., Ostiz M., Kutz M. and LaIglesia M. (20180102). [10-day triple therapy with esomeprazole 40 mg/12 h vs. quadruple concomitant non-bismuth therapy as first line treatment for Helicobacter pylori infection]. : Gastroenterologia y hepatologia.

MLA

Campillo Ana, Amorena Edurne, Ostiz Miriam, Kutz Marcos and LaIglesia Matilde. [10-day triple therapy with esomeprazole 40 mg/12 h vs. quadruple concomitant non-bismuth therapy as first line treatment for Helicobacter pylori infection]. : Gastroenterologia y hepatologia. 20180102.